Magdalena Biosciences develops novel, natural prescription medicines derived from plants.
Magdalena Biosciences has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in January 2023.
Magdalena Biosciences's investors include One Small Planet.
Magdalena Biosciences is headquartered in Dover, United States.
Magdalena Biosciences develops novel, natural prescription medicines derived from plants.
Magdalena Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Magdalena Biosciences — Funding & Investors." VCBacked, January 10, 2023, https://www.vcbacked.co/company/magdalena-biosciences. Accessed September 30, 2026.
VCBacked. (2023). Magdalena Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/magdalena-biosciences
{{cite web |title=Magdalena Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/magdalena-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated